Cargando…
SWELL signalling in adipocytes: can fat 'feel' fat?
Obesity is becoming a global epidemic, predisposing to Type 2 diabetes, cardiovascular disease, fatty liver disease, pulmonary disease, osteoarthritis and cancer. Therefore, understanding the biology of adipocyte expansion in response to overnutrition is critical to devising strategies to treat obes...
Autores principales: | Gunasekar, Susheel K., Xie, Litao, Sah, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768237/ https://www.ncbi.nlm.nih.gov/pubmed/31112068 http://dx.doi.org/10.1080/21623945.2019.1612223 |
Ejemplares similares
-
SWELL1 is a regulator of adipocyte size, insulin signaling and glucose homeostasis
por: Zhang, Yanhui, et al.
Publicado: (2017) -
Adipose-targeted SWELL1 deletion exacerbates obesity- and age-related nonalcoholic fatty liver disease
por: Gunasekar, Susheel K., et al.
Publicado: (2023) -
SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia
por: Kang, Chen, et al.
Publicado: (2018) -
SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism
por: Kumar, Ashutosh, et al.
Publicado: (2020) -
The SWELL1-LRRC8 complex regulates endothelial AKT-eNOS signaling and vascular function
por: Alghanem, Ahmad F, et al.
Publicado: (2021)